Finally, individuals with a history of heart failure, ischaemic heart disease, unstable angina, myocardial infarction, aortic aneurysm or dissection, stroke (ischaemic or haemorrhagic stroke), cerebral infarction, transient ischaemic attack, carotid intervention or surgery, coronary stenting, percutaneous coronary intervention (PCI) or coronary artery bypass before inclusion to the cohort or prior to the index event were also excluded
How often should you use GLP-1
[DOI] [PubMed] [Google Scholar] 164.Zhang L., Hanigan M.H
Key labs include a CMP to assess liver enzymes and kidney function, an A1c to track glycemic control, and a lipid panel to evaluate improvements in cardiovascular risk over time